p16INK4a gene promoter variation and differential binding of a repressor, the ras-responsive zinc-finger transcription factor, RREB

BALB/c mice are susceptible to the development of pristane-induced plasma cell tumors, and have a rare allelic variant in the coding region of the p16INK4a (p16) tumor suppressor gene that produces a protein with impaired activity. We have now found that the BALB/c p16 promoter has an allelic variant that may also compromise p16 activity. Following pristane treatment, BALB/c p16 mRNA levels in B cells were lower than that in DBA/2 or C.D2-Pctr1, a resistant BALB/c congenic strain that harbors DBA/2 chromatin surrounding the p16 locus. Four sequence variants were found between BALB/c and DBA/2 in the p16 promoter region. In reporter assays, the DBA promoter was at least four times more active in driving luciferase expression than the BALB/c promoter. Most of the difference in activity was localized to a single nucleotide deletion in BALB/c. This deletion created a consensus binding site for RREB, a ras-responsive transcriptional element with zinc-finger binding motifs. Transient transfections with RREB confirmed that the p16 promoter can be downregulated by RREB, in a Ras- or Mek-dependent manner, and that the BALB/c promoter is more sensitive than DBA/2 to regulation by RREB. BALB/c mice have both regulatory and coding region defects that may contribute to the impairment of p16 gene function.

[1]  R. T. Brown,et al.  An Acute Phase Response Factor/NF-B Site Downstream of the junB Gene That Mediates Responsiveness to Interleukin-6 in a Murine Plasmacytoma (*) , 1995, The Journal of Biological Chemistry.

[2]  M. Potter,et al.  Genetic Considerations in Plasmacytomas of BALB/c, NZB, and (BALB/c X NZB) F1 Mice , 1980 .

[3]  D. Carrasco,et al.  Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis , 2001, Nature.

[4]  S. Baylin,et al.  Sequence-specific DNA Binding Activity of RNA Helicase A to thep16INK4a Promoter* , 2001, The Journal of Biological Chemistry.

[5]  J. Stone,et al.  RAS signalling is abnormal in a c-raf1 MEK1 double mutant , 1995, Molecular and cellular biology.

[6]  M. You,et al.  The 5′-flanking region of the E1 α form of the murine p16INK4a (MTS1) gene ☆ , 1996 .

[7]  Peter A. Jones,et al.  The fundamental role of epigenetic events in cancer , 2002, Nature Reviews Genetics.

[8]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[9]  S. Baylin,et al.  Altered methylation patterns in cancer cell genomes: cause or consequence? , 2002, Cancer cell.

[10]  M. You,et al.  Cdkn2a encodes functional variation of p16INK4a but not p14ARF, which confers selection in mouse lung tumorigenesis , 1999, Molecular carcinogenesis.

[11]  David M. Livingston,et al.  Functional interactions of the retinoblastoma protein with mammalian D-type cyclins , 1993, Cell.

[12]  Y. Qian,et al.  The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle , 1991, Cell.

[13]  T. Tong,et al.  Characterization of Regulatory Elements on the Promoter Region of p16INK4a That Contribute to Overexpression of p16 in Senescent Fibroblasts* , 2001, The Journal of Biological Chemistry.

[14]  B. Mock,et al.  The role of p16INK4a (Cdkn2a) in mouse plasma cell tumors. , 1999, Current topics in microbiology and immunology.

[15]  M. Potter,et al.  The plasmacytoma resistance gene, Pctr2, delays the onset of tumorigenesis and resides in the telomeric region of chromosome 4. , 1997, Blood.

[16]  A. Berns,et al.  Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice , 2001, Nature.

[17]  M. Ewen,et al.  Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. , 1993, Genes & development.

[18]  E. Wagner,et al.  JunB suppresses cell proliferation by transcriptional activation of p16INK4a expression , 2000, The EMBO journal.

[19]  D. Dilworth,et al.  Germline CDKN2A mutation implicated in predisposition to multiple myeloma. , 2000, Blood.

[20]  W. Clark,et al.  Germline p16 mutations in familial melanoma , 1994, Nature Genetics.

[21]  S. Shurtleff,et al.  D-type cyclin-dependent kinase activity in mammalian cells , 1994, Molecular and cellular biology.

[22]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[23]  M Mabry,et al.  RREB-1, a novel zinc finger protein, is involved in the differentiation response to Ras in human medullary thyroid carcinomas , 1996, Molecular and cellular biology.

[24]  B. Mock,et al.  Genetic mapping of tumor susceptibility genes involved in mouse plasmacytomagenesis. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[25]  E. Ramsay,et al.  Cdkn2a, the cyclin-dependent kinase inhibitor encoding p16INK4a and p19ARF, is a candidate for the plasmacytoma susceptibility locus, Pctr1. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[26]  S. Rudikoff,et al.  Interleukin 6 is essential for in vivo development of B lineage neoplasms , 1995, The Journal of experimental medicine.

[27]  G. Peters,et al.  Opposing effects of Ets and Id proteins on p16INK4a expression during cellular senescence , 2001, Nature.

[28]  G. Gores,et al.  p16INK4a promoter mutations are frequent in primary sclerosing cholangitis (PSC) and PSC-associated cholangiocarcinoma. , 2002, Gastroenterology.

[29]  R. Alani,et al.  Id1 regulation of cellular senescence through transcriptional repression of p16/Ink4a , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[30]  R. Bataille,et al.  IL‐6 up‐regulates Mcl‐1 in human myeloma cells through JAK / STAT rather than Ras / MAP kinase pathway , 1999, European journal of immunology.

[31]  R. Nordan,et al.  A macrophage-derived factor required by plasmacytomas for survival and proliferation in vitro. , 1986, Science.

[32]  R. DePinho,et al.  Efficiency Alleles of the Pctr1 Modifier Locus for Plasmacytoma Susceptibility , 2001, Molecular and Cellular Biology.

[33]  M. Potter,et al.  Induction of plasmacytomas with silicone gel in genetically susceptible strains of mice. , 1994, Journal of the National Cancer Institute.

[34]  M. Potter,et al.  Induction of Plasma-Cell Neoplasms in Strain BALB/c Mice with Mineral Oil and Mineral Oil Adjuvants , 1962, Nature.

[35]  D. Lowy,et al.  Ras-Specific Exchange Factor GRF: Oligomerization through Its Dbl Homology Domain and Calcium-Dependent Activation of Raf , 1999, Molecular and Cellular Biology.